ProQuest Associates IV LLC, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 171,405 shares at $83.00 ($14.2M) on 2017-03-27, disclosed to the SEC on 2017-03-29.
Open-market sale of $14.2M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.00 | 400 | $33K | 0.2% |
| 2 | $83.00 | 1,300 | $108K | 0.8% |
| 3 | $83.00 | 37,731 | $3.1M | 22.0% |
| 4 | $83.02 | 6,182 | $513K | 3.6% |
| 5 | $83.02 | 6,182 | $513K | 3.6% |
| 6 | $83.01 | 500 |
| $42K |
| 0.3% |
| 7 | $83.01 | 1,600 | $133K | 0.9% |
| 8 | $83.01 | 58,755 | $4.9M | 34.3% |
| 9 | $83.01 | 58,755 | $4.9M | 34.3% |
| Total | $83.01 avg | 171,405 | $14.2M | 100% |
| Filing → |
| EGRX | SELL | 2016-11-14 | $4.2M | — | Filing → |
| EGRX | SELL | 2016-11-04 | $21.0M | — | Filing → |
| EGRX | SELL | 2016-09-30 | $10.9M | — | Filing → |